Brookfield Corporation (BN) Stock Price & How to Invest

Brookfield Corporation sits at the top of the Brookfield group and reports through three pillars. Asset management runs through its roughly 73% interest in Brookfield Asset Management, whose fee-bearing capital reached a record ~$672 billion at the end of June 2026, up ~19% year over year, after record quarterly fundraising of ~$77 billion; Brookfield completed its acquisition of the rest of credit manager Oaktree in July 2026. Wealth solutions is the annuity, pension-risk-transfer and P&C insurance business (Brookfield Wealth Solutions, built from American National, Argo Group, American Equity Life and, since the 2026 acquisition, UK annuity provider Just Group) that gathers policyholder money and invests it alongside Brookfield's own funds; insurance assets reached ~$191 billion at mid-year, including ~$45 billion added by Just Group. The third pillar is the operating businesses, held partly through the listed affiliates: Brookfield Renewable (BEP/BEPC), Brookfield Infrastructure (BIP/BIPC), Brookfield Business Partners (BBU/BBUC) and a wholly owned real estate book that includes Canary Wharf, Brookfield Place and Ala Moana Center. Bruce Flatt has run the company since 2002, and the December 2022 reorganisation is what created the BN-versus-BAM split: BN kept the balance sheet and the carried interest, BAM was carved out as the pure-play, high-payout manager.

The investment picture is a valuation puzzle as much as a business question. Shares closed at ~$36.84 on October 16, 2026, down ~21% year to date, ~13% over three months and ~16% over one year, for a market capitalisation of ~$82 billion against revenue of ~$81 billion over the trailing twelve months. Net income attributable to shareholders over the last twelve months was only ~$1.4 billion, which puts the reported P/E in the high 60s on Yahoo's figures. That gap exists because consolidation drags in revenue and assets Brookfield does not own outright, and because depreciation on long-lived infrastructure suppresses accounting profit. Management therefore steers investors to distributable earnings: ~$1.5 billion or ~$0.66 per share in the second quarter of 2026 and ~$6.2 billion (~$2.61 per share) over twelve months, with distributable earnings before realizations up ~15% per share to ~$0.61. The dividend is deliberately small, ~$0.28 per share annualised for a yield near ~0.8%, because capital is retained for buybacks and new commitments; Brookfield bought back ~$580 million of shares in the first half at an average of ~$42. A structural simplification approved by shareholders on July 16, 2026 will fold Brookfield Wealth Solutions into a new parent that keeps the BN ticker on both exchanges. Third quarter 2026 results are scheduled for November 12, 2026.

The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. Leverage sits mostly at the asset level in non-recourse form (Yahoo shows ~$269 billion of consolidated debt), which limits contagion but leaves refinancing exposed to long rates and credit spreads across hundreds of separate structures. The office and retail real estate book has already required writedowns and remains the least liquid piece, though leasing improved in 2026. The insurance pillar, now larger after Just Group, introduces a different risk set entirely: spread compression if rates fall, reserve assumptions on long-dated annuities, and regulators in multiple jurisdictions reviewing private-capital ownership of annuity liabilities. Integrating Oaktree adds execution risk in credit. Carried interest and realization gains depend on exit markets that shut for long stretches, and BN's ~1.8 beta means the stock has historically fallen harder than the index when sentiment turns, as the ~21% decline in 2026 shows.

10 analysts publish price targets on BN, averaging $53.75 against a $41.83 price as of November 2026, or +28.5%. The published targets run from $31.00 to $61.00, a moderate spread, and the ratings split 10 buy, 0 hold, 1 sell. Over the last six months there have been 3 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full BN forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Brookfield Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Fee-bearing capital and carried interest at BAM. BAM's fee-bearing capital of ~$672 billion at the end of the second quarter of 2026 grew ~19% year over year and fee-related earnings rose ~20%, driven by a record ~$77 billion of quarterly inflows; the seventh private equity flagship ($7 billion) and sixth infrastructure flagship ($9 billion) are each on track to be the largest in their series. The most optimistic published target, $61.00, assumes this works close to its best case.

The case against. The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. The most pessimistic target, $31.00, is roughly what BN is worth if this bites instead.

Read the full bull and bear case on BN, including what would have to change to break either one. Walnut is not an investment adviser.

Yes. Brookfield Corporation (BN) has had 3 share splits in the last 10 years:

• 3:2 on April 2, 2020, so every share held became 1.5 shares.
• 1237:1000 on December 12, 2022, so every share held became 1.237 shares.
• 3:2 on October 10, 2025, so every share held became 1.5 shares.

A split changes the share count and the price per share and leaves the value of a holding unchanged. Someone holding $1,000 of BN the day before the 3:2 split held $1,000 the day after, in more shares at a proportionally lower price. Historical prices from before the date are normally shown split-adjusted, which is why a long-run chart shows no cliff.

Splits matter mainly because they make older price figures confusing to compare by hand, and because a board choosing to split is usually signalling that the price has run up far enough to feel awkward for smaller buyers. Neither is a reason to buy or sell.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Brookfield Corporation's investor relations page or your broker.

• Share price / market cap: ~$36.84 per share, ~$82 billion (Oct 16, 2026 close)
• Revenue (TTM): ~$81 billion
• Net income attributable (TTM): ~$1.4 billion, a reported P/E in the high 60s
• Distributable earnings (Q2 2026): ~$1.5 billion, ~$0.66 per share (~$0.61 before realizations, up ~15%)
• Distributable earnings (TTM): ~$6.2 billion, ~$2.61 per share
• Fee-bearing capital at BAM: ~$672 billion, up ~19% year over year
• Dividend: ~$0.28 per share annualised, ~0.8% yield

At ~$36.84 the shares trade at roughly 14 times trailing distributable earnings of ~$2.61 per share, cheaper than earlier in 2026 after a ~21% slide, while the reported P/E in the high 60s is not a like-for-like multiple: depreciation on infrastructure and the share of consolidated profit belonging to outside partners both sit between revenue and attributable earnings. Brookfield's own buybacks earlier in the year averaged ~$42, above the current price. Third quarter 2026 results are scheduled for November 12, 2026.

Other names that sit close to BN: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

There are three common ways to get BN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so BN sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

BN is the compounding parent of the Brookfield complex, and the trade-off is that its economics arrive through carried interest, insurance spread and asset-level equity rather than through clean reported earnings. In October 2026 that trade-off is priced cheaply: the stock sits near its 52-week low while fee-bearing capital, insurance assets and distributable earnings all set records.

Whether BN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BN a buy or a sell?, and where the stock could go from here in the BN stock forecast.

For income investors, whether BN pays a dividend and how the payout looks is covered in does BN pay a dividend? And to weigh BN against a peer, read the full side-by-side comparisons: BN vs BX and BN vs KKR.